US FDA’s Coronavirus Workload Shifting Beyond Idea Stage

 
• By Derrick Gingery

Pre-IND inquiries are slowing and the FDA says more late-stage development work is coming.

Coronavirus
The evolution of industry approaches to the pandemic is typical for situations where there is a critical needs for treatments quickly. • Source: Shutterstock

More from Product Reviews

More from Pink Sheet